SELLAS Life Sciences Group and World-Renowned Cancer Center to Study Galinpepimut-S (GPS) in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma (MPM)

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence